0
CLINICAL NOTES   |    
THE RELATION OF ATTITUDE TOWARD MEDICATION TO TREATMENT OUTCOMES IN CHEMOTHERAPY
DONALD R. GORHAM; LEWIS J. SHERMAN
Am J Psychiatry 1961;117:830-832.
View Article Information
VA Central NP Research Laboratory, Perry Point, Md.
VA Hospital, Brockton, Mass.
text A A A
PDF of the full text article.
Abstract
An Attitude Toward Medication Scale was administered before and after treatment to 369 patients in a large-scale chemotherapy study. The hypothesis that the attitude of patients toward medication has an important bearing on treatment effect was not upheld with this population of chronic, apathetic schizophrenics. Medication attitude, however, was significantly related to a cluster of symptoms that tend to characterize paranoid schizophrenics indicating that the more paranoid the patient, the less faith he had that he might be helped by medication.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Psychiatric News
    PubMed Articles
    Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
    The New England journal of medicine 2012 Jan 26
    A phase 3 trial of bevacizumab in ovarian cancer.
    The New England journal of medicine 2011 Dec 29